Key facts
- This page summarizes Snehal Patel's Form 4 filing for Greenwich LifeSciences, Inc. (GLSI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Nov 2025, 06:05.
Snehal Patel - 13 Nov 2025 Form 4 Insider Report for Greenwich LifeSciences, Inc. (GLSI)
- Reporting relationship
- CEO and CFO, Director, 10%+ Owner
- Issuer ticker
- GLSI
- Reported as of
- 13 Nov 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Nov 2025, 06:05:39 UTC
- Prior SEC filing
- 12 Nov 2025
- Next SEC filing
- 28 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Snehal Patel
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Snehal Patel filed Form 4 for Greenwich LifeSciences, Inc. (GLSI) on 17 Nov 2025.
Change
- Previous filing in this sequence was filed on 12 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001806920
Primary reporting owner
Patel Snehal
- Relationship
- CEO and CFO, Director, 10%+ Owner
- Address
- C/O GREENWICH LIFESCIENCES, INC., 3992 BLUEBONNET DR., BUILDING 14, STAFFORD
- Signature
- /s/ Snehal Patel
- Signature date
- 17 Nov 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GLSI
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- +4.4%
- Price
- $0.000000
- Shares after
- 2,347,462
- Date
- 13 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $8.20
* marks a reported price that did not pass the local price check.